A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).
Patients aged 18 years and older.
Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.
ALS patients treated with traditional Chinese medicine.
Patients who refuse informed consent.
Patients who meet the criteria will be enrolled from multi-centers in China.
Other
Prospective
Not listed
Effective Survival
The time from disease onset to death, tracheostomy, or permanent assisted ventilation
Overall Survival
Death owing to any causes
Rate of Disease Progression
(48-total ALSFRS-R)/symptom duration (months)
Rate of Forced Vital Capacity (FVC) Decline
The slope of decline of forced vital capacity (FVC) to assess the respiratory function.
Rate of Body Mass Index (BMI) Decline
The slope of decline of body mass index (BMI) to assess the disease progression.
Click on the lead sponsor to view all of their trials.
